DGAP-Adhoc: MOLOGEN AG - Amendment Rights Offering of a Convertible Bond: Reducing of the Conversion Price

Publication of an inside information pursuant to Section 17 of the regulation (EU) No. 596/2014

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

MOLOGEN AG - Amendment Rights Offering of a Convertible Bond: Reducing of the Conversion Price

Berlin, 27 December 2018 - MOLOGEN AG (ISIN DE000A2LQ900, SIN A2L Q90) (the "Company") today decided on the amendment of the rights offering of a new convertible bond 2019/2027, announced via ad hoc notification on 19 December 2018 and published in the German Federal Gazette (Bundesanzeiger) on 21 December 2018 to reduce the initial conversion price and to adjust the convertible bonds aggregate face value accordingly.

Specifically, the Executive Board of the Company today resolved, with the approval of the Supervisory Board and with regards to the recent trend of the share price, to reduce the initial conversion price of the convertible bond 2019/2027 from initially intended EUR 2.467 to now 2.0805 in order to create an additional incentive for subscription. As a result of the amendment the aggregate face value and the expected issue proceeds will decrease from initially up to EUR 3,210,400.00 to now up to 2,707,050.00. The subscription ratio will by adjusted accordingly. Apart from that, the terms of the issuance remain essentially the same. The amended rights' offering is expected to be published in the Federal Gazette on 31. December 2018. Pursuant to legal regulations, the Company will still not prepare and publish a prospectus pertaining to the public offering of the convertible bond 2019/2027.

Important note:
This announcement is not an offer of securities for sale in the United States, Australia, Canada, Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The securities referred to in this press release have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offering of the securities in the United States of America. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan.